Skip to main content
icon for 2026年の米国のはしか症例は?

2026年の米国のはしか症例は?

icon for 2026年の米国のはしか症例は?

2026年の米国のはしか症例は?

Polymarket

$7,830,948 Vol.

Polymarket

$7,830,948 Vol.

↑4.5千

$20 Vol.

42%

↑3k

$90,114 Vol.

95%

↑3.5千

$13,530 Vol.

92%

↑4k

$220,549 Vol.

75%

↑5千

$230,428 Vol.

26%

↑7.5千

$185,031 Vol.

12%

↑1万

$6,515,593 Vol.

6%

↑12.5k

$349,917 Vol.

5%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission driven by vaccination gaps below the 95% herd immunity threshold continues to fuel record U.S. case counts in 2026. As of August 13, the CDC reports 2,566 confirmed cases—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 38 new outbreaks and 94% of infections outbreak-associated across 47 jurisdictions. Most cases involve unvaccinated individuals, including 20% under age 5, reflecting imported introductions and local chains in under-immunized communities. CDC weekly updates and state surveillance reports will shape trader views on whether totals remain elevated through year-end, while any Pan American Health Organization review of elimination status could highlight ongoing risks from declining routine MMR coverage.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
音量
$7,830,948
終了日
2026/12/31
マーケット開始日
Feb 16, 2026, 11:51 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission driven by vaccination gaps below the 95% herd immunity threshold continues to fuel record U.S. case counts in 2026. As of August 13, the CDC reports 2,566 confirmed cases—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 38 new outbreaks and 94% of infections outbreak-associated across 47 jurisdictions. Most cases involve unvaccinated individuals, including 20% under age 5, reflecting imported introductions and local chains in under-immunized communities. CDC weekly updates and state surveillance reports will shape trader views on whether totals remain elevated through year-end, while any Pan American Health Organization review of elimination status could highlight ongoing risks from declining routine MMR coverage.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
音量
$7,830,948
終了日
2026/12/31
マーケット開始日
Feb 16, 2026, 11:51 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

外部リンクに注意してください。

よくある質問

「2026年の米国のはしか症例は?」はPolymarket上の11個の結果が可能な予測市場で、トレーダーが何が起こるかに基づいてシェアを売買します。現在のリード結果は「↑500」で100%、次いで「↑1k」が100%です。価格はコミュニティのリアルタイム確率を反映しています。例えば、100¢で取引されているシェアは、市場がその結果に100%の確率を集合的に割り当てていることを意味します。これらのオッズは継続的に変化します。正しい結果のシェアは市場決済時に各$1で引き換え可能です。

本日現在、「2026年の米国のはしか症例は?」は$7.8 millionの総取引量を生み出しています(Dec 1, 2025のマーケット開始以来)。この取引活動レベルはPolymarketコミュニティの強い関与を反映し、現在のオッズが幅広い市場参加者によって形成されていることを保証します。このページで直接、ライブの価格変動を追跡し、任意の結果で取引できます。

「2026年の米国のはしか症例は?」で取引するには、このページに記載されている11個の利用可能な結果を閲覧します。各結果には市場の暗示確率を表す現在の価格が表示されています。ポジションを取るには、最も可能性が高いと思う結果を選び、「はい」で支持するか「いいえ」で反対するかを選択し、金額を入力して「取引」をクリックします。選んだ結果が市場決済時に正しければ、「はい」のシェアは各$1を支払います。正しくなければ$0です。決済前にいつでもシェアを売却できます。

「2026年の米国のはしか症例は?」の現在のフロントランナーは「↑500」で100%であり、市場がこの結果に100%の確率を割り当てていることを意味します。次に近い結果は「↑1k」で100%です。これらのオッズはトレーダーがシェアを売買するにつれてリアルタイムで更新されます。頻繁に確認するか、このページをブックマークしてください。

「2026年の米国のはしか症例は?」の決済ルールは、各結果が勝者と宣言されるために何が起こる必要があるかを正確に定義しています。これには結果を決定するために使用される公式データソースも含まれます。このページのコメント上にある「ルール」セクションで完全な決済基準を確認できます。取引前にルールを注意深く読むことをお勧めします。